our board

Meghan sees joining the Board of Ovarian Cancer Australia as a chance to give back to an organisation that provided so much support and ensured she didn’t battle ovarian cancer alone.  Her ambition is to bring her commercial business expertise with a consumer’s insight and to assist Ovarian Cancer Australia to achieve its bold 2025 vision to reduce the incidence and improve the survival rates of ovarian cancer.

Formerly a partner at Deloitte (2011-2020), and the co-founder of Aequus Partners (2000-2011), Juliet has advised over 200 global organisations on people and culture issues, including American Airlines, APRA, the Australian Army, BHP, Gilead Sciences, Johson & Johnson, Macquarie Group, Qantas, the RBA, Toyota, the United Nations and Woodside. She has served on three Diversity Councils, namely for the RBA, the Australian Navy and Deloitte Australia. Juliet started her career as a lawyer, firstly working in criminal law for the Commonwealth Director of Prosecutions and then in employment law. 

Juliet is a TEDx speaker, a 2019 Australian Financial Review Top 100 Women of Influence and is well known for her thought leadership on diversity and inclusion. She has published in the Harvard Business Review, the Australian Financial Review and The Guardian. Her most recent book (published by the Australian Institute of Company Directors) is “Which two heads are better than one? The extraordinary power of diversity of thinking and inclusive leadership” (2021)).  

Juliet holds a BA (Psychology Major), LLB, LLM (with Hons) and is a final year PhD candidate (Business School, Brunel University London).   

While Marise started as an auditor, she changed focus in 2012 using deep problem-solving and analytical skills to work with companies to enable change (often from ‘developing’ to leading practices), resolve complex business issues and lead finance transformation. Being an auditor for 20+ years and working in various industries provided a great springboard to something new. 

Marise has a solid track record working with executives in various industries resolving intricate finance and business issues using years of varied experience to consistently deliver successful outcomes and manage multiple stakeholders. In her current role she works directly with key finance executives in some of Australia’s most iconic companies to help improve the effectiveness of their finance function in the context of business challenges to facilitate and create effective solutions and efficiencies.

Karen trained as a nurse in Edinburgh, where she worked in various surgical units and Marie Curie Cancer Care Hospice, before moving into academic positions. Karen’s research is focused on the lived experiences of people affected by cancer, seeking to understand how health care professionals can better support people and their families who are affected by cancer. Karen is recognised as an expert in the fields of cancer and palliative care nursing through various appointments including as invited member of the Professional Advisory Council of the Cancer Nurses Society of Australia and two Visiting Professor appointments with international universities in New Zealand and Scotland.  

Karen has held a number of board level appointments including Board Chair to Canberra College in the ACT, and previously as Non-Executive Director of Alcohol and Drugs Action, Aberdeen, Scotland. Within the University of Canberra, she is a Professorial member of the University Academic Board and Education Committees. Karen holds statutory appointments as member of the Nursing and Midwifery Board of Australia ACT Board, and as Council of Deans of Nursing and Midwifery member of the Commonwealth Nursing and Midwifery Strategic Reference Group. 

Karen is a registered nurse and holds a PhD in Nursing from Edinburgh Napier University (Scotland) as well as being a Fellow of the European Academy of Nursing and the Higher Education Academy (UK).